📖

entities-gfap

wiki page Created: 2026-04-02T17:01:41 By: crosslink-v2 Quality: 50% ✓ SciDEX ID: wiki-entities-gfap

🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

Linked Artifacts (364)

mentions🧫Blood Biomarker vs Tau PET for Treatment Monitoring90%

mentions🧪GFAP-Positive Reactive Astrocyte Subtype Delineation90%

related🧪GFAP-Positive Reactive Astrocyte Subtype Delineation90%

mentions🧫iPSC-NPC effects on astrocytes in vitro ICH model80%

mentions🔬Neuroinflammation and microglial priming in early Alzheimer&75%

related🧫iPSC-NPC effects on astrocytes in vitro ICH model72%

mentions🧪GFAP-Positive Reactive Astrocyte Subtype Delineation70%

mentions🧫GWAS of composite biomarker score70%

mentions🧫Plasma ATN biomarkers across AD continuum in Chilean cohort70%

mentions🧫Real-world safety study of Lecanemab in Japanese AD patients70%

mentions🧫iPSC-NPC transplantation in ICH animal model70%

mentions🧫GWAS of plasma GFAP in East Asian cohort70%

mentions🧫Proposed experiment from debate on Astrocytes adopt A1 (neur70%

mentions🧫s:** - ALOX15 overexpression in healthy astrocytes should be70%

mentions🧫Proposed experiment from debate on Epigenetic clocks and bio70%

mentions🧫s:** - Compare tau strain spreading in EXT1/EXT2 conditional70%

mentions🧫s:** - Dose-response studies showing therapeutic window with70%

mentions🧫Proposed experiment from debate on Microglia activate astroc70%

mentions🧫AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi70%

mentions🧫Why Does Amyloid Removal Only Slow Decline 27%? — Mechanisti70%

mentions🧫Anti-Tau Immunotherapy Dosing Optimization70%

mentions🧫ApoE4 Function in Alzheimer's Disease70%

mentions🧫Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson&70%

mentions🧫Blood-Based Biomarker Panel for Early AD Detection70%

mentions🧫Blood Biomarker vs Tau PET for Treatment Monitoring70%

mentions🧫Cognitive Reserve Mechanisms in Alzheimer's Disease — M70%

mentions🧫Mechanism: Selective Vulnerability of Dopaminergic Neurons i70%

mentions🧫Down Syndrome Alzheimer's Disease: Mechanisms and Thera70%

mentions🧫Frontal and Temporal Lobe Selective Vulnerability in FTD — M70%

mentions🧫FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation70%

mentions🧫Lifestyle Intervention Mechanisms in Alzheimer's Diseas70%

mentions🧫Neural Stem Cell Therapy for Alzheimer's Disease70%

mentions🧫Normal Aging to Alzheimer's Disease Transition Trigger 70%

mentions🧫CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs 70%

mentions🧫Presymptomatic GRN Carrier Intervention Timing — Biomarker-G70%

mentions🧫PSP and CBS Biomarker Validation Study70%

mentions🧫SCFA-Mediated Neuroinflammation in Alzheimer's Disease70%

mentions🧫Sex Differences in Alzheimer's Disease — mechanisms and70%

mentions🧫Traumatic Brain Injury and Alzheimer's Disease Relation70%

mentions🧫Biomechanical Impact Profiles and Chronic Traumatic Encephal70%

related🧫Cytochrome Therapeutics70%

related🧫Blood Biomarker vs Tau PET for Treatment Monitoring70%

see_also🧪GFAP-Positive Reactive Astrocyte Subtype Delineation70%

related🔬Neuroinflammation and microglial priming in early Alzheimer&67%

related🧫GWAS of composite biomarker score63%

related🧫Plasma ATN biomarkers across AD continuum in Chilean cohort63%

related🧫Real-world safety study of Lecanemab in Japanese AD patients63%

related🧫iPSC-NPC transplantation in ICH animal model63%

related🧫GWAS of plasma GFAP in East Asian cohort63%

related🧫Proposed experiment from debate on Astrocytes adopt A1 (neur63%

related🧫s:** - ALOX15 overexpression in healthy astrocytes should be63%

related🧫Proposed experiment from debate on Epigenetic clocks and bio63%

related🧫s:** - Compare tau strain spreading in EXT1/EXT2 conditional63%

related🧫s:** - Dose-response studies showing therapeutic window with63%

related🧫Proposed experiment from debate on Microglia activate astroc63%

related🧫AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi63%

related🧫Why Does Amyloid Removal Only Slow Decline 27%? — Mechanisti63%

related🧫Anti-Tau Immunotherapy Dosing Optimization63%

related🧫ApoE4 Function in Alzheimer's Disease63%

related🧫Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson&63%

related🧫Blood-Based Biomarker Panel for Early AD Detection63%

related🧫Blood Biomarker vs Tau PET for Treatment Monitoring63%

related🧫Cognitive Reserve Mechanisms in Alzheimer's Disease — M63%

related🧫Mechanism: Selective Vulnerability of Dopaminergic Neurons i63%

related🧫Down Syndrome Alzheimer's Disease: Mechanisms and Thera63%

related🧫Frontal and Temporal Lobe Selective Vulnerability in FTD — M63%

related🧫FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation63%

related🧫Lifestyle Intervention Mechanisms in Alzheimer's Diseas63%

related🧫Neural Stem Cell Therapy for Alzheimer's Disease63%

related🧫Normal Aging to Alzheimer's Disease Transition Trigger 63%

related🧫CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs 63%

related🧫Presymptomatic GRN Carrier Intervention Timing — Biomarker-G63%

related🧫PSP and CBS Biomarker Validation Study63%

related🧫SCFA-Mediated Neuroinflammation in Alzheimer's Disease63%

related🧫Sex Differences in Alzheimer's Disease — mechanisms and63%

related🧫Traumatic Brain Injury and Alzheimer's Disease Relation63%

related🧫Biomechanical Impact Profiles and Chronic Traumatic Encephal63%

see_also📖PSD-95 (Postsynaptic Density Protein 95)60%

see_also📖adam1060%

see_also📖EEF2K — Eukaryotic Elongation Factor 2 Kinase60%

see_also📖JNK1 (MAPK8)60%

see_also📖NTF3 — Neurotrophin-360%

see_also📖RCAN1 Gene60%

see_also📖SMAD1 Gene60%

see_also📖SMAD2 Gene60%

see_also📖TLR6 Gene60%

see_also📖tnfaip360%

see_also📖Neurogranin (Ng) - Synaptic Biomarker60%

see_also📖ABCA7 (Redirect)60%

see_also📖ACTB Gene60%

see_also📖AIF1 Gene60%

see_also📖MYT1L Gene60%

see_also📖NCF1 — Neutrophil Cytosolic Factor 160%

see_also📖OLIG2 Gene60%

see_also📖OSMR Gene60%

see_also📖RPL24 — Ribosomal Protein L2460%

see_also📖RPS23 — Ribosomal Protein S2360%

see_also📖tpm260%

see_also📖Neurogranin-Guided Synapse Rescue Therapy60%

see_also📖Aging vs Neurodegeneration: Mechanistic Comparison Matrix60%

see_also📖Neurogranin (RC3)60%

see_also📖Neuronal Nitric Oxide Synthase60%

see_also📖Reactive Astrocytes (A2 Phenotype)60%

see_also📖Reactive Astrocytes in Neurodegeneration60%

see_also📖Reactive Astrocytes in Neuroinflammation60%

see_also📖IL16 Gene60%

see_also📖IL9 (Interleukin 9)60%

see_also📖NPTX1 — Neuronal Pentraxin 160%

see_also📖NPTX1 Protein60%

see_also📖ACSL4 Gene - Acyl-CoA Synthetase Long Chain Family Member 460%

see_also📖SCRIB Gene60%

see_also📖Excitotoxicity60%

see_also📖Hippocampus60%

see_also📖dlk260%

see_also📖LIF — Leukemia Inhibitory Factor60%

see_also📖LIFR - Leukemia Inhibitory Factor Receptor60%

see_also📖VGF — VGF Nerve Growth Factor Inducible60%

see_also📖VGF Nerve Growth Factor60%

see_also📖CHRNA6 Gene60%

see_also📖ELAVL3 Gene60%

see_also📖hes160%

see_also📖MAG Gene60%

see_also📖NOX2 Gene60%

see_also📖OLIG1 Gene60%

see_also📖PLP1 Gene60%

see_also📖RAB3B Gene60%

see_also📖NOX2/CYBB (NADPH Oxidase 2)60%

see_also📖RAB3B Protein60%

see_also📖Ubiquitin C-terminal Hydrolase L1 (UCH-L1)60%

see_also📖Ceftriaxone ALS Trial60%

see_also📖ACTG1 Gene60%

see_also📖ATP5A1 Gene60%

see_also📖cct260%

see_also📖JUND Gene - JunD Transcription Factor60%

see_also📖MT1A (Metallothionein-1A)60%

see_also📖NOS1 — Nitric Oxide Synthase 160%

see_also📖PSMA3 Gene60%

see_also📖SYNGR3 Gene60%

see_also📖UCHL1 Gene60%

see_also📖Ceftriaxone for Amyotrophic Lateral Sclerosis60%

see_also📖astrocyte-neuron-metabolic-coupling-parkinsons60%

see_also📖Astrocytes60%

see_also📖Neuroprotection Strategies in Neurodegeneration60%

see_also📖Hippocampal CA1 Pyramidal Neurons60%

see_also📖metformin-add-on-levodopa-pd-nct0705595860%

see_also📖biomarkers60%

see_also📖Biomarkers for Corticobasal Degeneration60%

see_also📖Biomarkers to Distinguish FTLD-tau from FTLD-TDP60%

see_also📖Biomarkers for Multiple System Atrophy60%

see_also📖Biomarkers for Progressive Supranuclear Palsy60%

see_also📖Biomarkers in Parkinsonian Syndromes (NCT06501469)60%

see_also📖4D Molecular Therapeutics60%

see_also📖Alzheimer's Digital Therapeutics Companies60%

see_also📖AD Exosome and Extracellular Vesicle Companies60%

see_also📖AD RNA-Based Therapeutics Companies60%

see_also📖Alectos Therapeutics Inc60%

see_also📖Aleza Therapeutics60%

see_also📖Alterity Therapeutics60%

see_also📖Amyl Therapeutics60%

see_also📖Appvian Therapeutics60%

see_also📖Arvinas Therapeutics60%

see_also📖Axial Therapeutics60%

see_also📖Axsome Therapeutics, Inc.60%

see_also📖BlueRock Therapeutics60%

see_also📖BrainStorm Cell Therapeutics Inc.60%

see_also📖Capricor Therapeutics60%

see_also📖Cerevel Therapeutics60%

see_also📖Chelsea Therapeutics60%

see_also📖Click Therapeutics60%

see_also📖Convelo Therapeutics60%

see_also📖CRISPR Therapeutics60%

see_also📖cyclo-therapeutics60%

see_also📖cynata-therapeutics60%

see_also📖Cytochrome Therapeutics60%

see_also📖Denali Therapeutics60%

see_also📖Encoded Therapeutics60%

see_also📖Evox Therapeutics60%

see_also📖Finch Therapeutics60%

see_also📖Fulcrum Therapeutics60%

see_also📖heqIX Therapeutics60%

see_also📖Iduna Therapeutics60%

see_also📖IFM Therapeutics60%

see_also📖Inception Therapeutics60%

see_also📖Karuna Therapeutics60%

see_also📖Koneqia Therapeutics60%

see_also📖Lexeo Therapeutics60%

see_also📖Lysoway Therapeutics60%

see_also📖Lyterian Therapeutics60%

see_also📖Monte Rosa Therapeutics60%

see_also📖Muna Therapeutics60%

see_also📖Neteo Therapeutics60%

see_also📖NeuBase Therapeutics60%

see_also📖NeuExo Therapeutics60%

see_also📖Neumora Therapeutics60%

see_also📖NeuroMito Therapeutics60%

see_also📖Paxos Therapeutics60%

see_also📖Parkinson's Disease Digital Therapeutics Companies60%

see_also📖pd-exosome-therapeutics60%

see_also📖PD RNA Therapeutics Companies60%

see_also📖Pear Therapeutics60%

see_also📖Pinteon Therapeutics60%

see_also📖Prevail Therapeutics60%

see_also📖Rodin Therapeutics60%

see_also📖Sage Therapeutics60%

see_also📖Sangamo Therapeutics60%

see_also📖Spark Therapeutics60%

see_also📖Spin Therapeutics60%

see_also📖Stoke Therapeutics60%

see_also📖Synaptic Therapeutics60%

see_also📖Synchronicity Therapeutics60%

see_also📖T3D Therapeutics60%

see_also📖Trefoil Therapeutics60%

see_also📖Vator Therapeutics Inc.60%

see_also📖Ventus Therapeutics60%

see_also📖Voyager Therapeutics60%

see_also📖VTV Therapeutics60%

see_also📖Yumanity Therapeutics60%

see_also📖MDS 2026 — Emerging Therapeutics in Parkinson's Disease60%

see_also📖alzheimers-disease60%

see_also📖Aleza Therapeutics60%

see_also📖Denali Therapeutics60%

see_also📖4R Tauopathy Therapeutics — Investment Landscape Analysis60%

see_also📖Adult Neurogenesis Therapeutics Investment Landscape60%

see_also📖Anti-Tau Therapeutics: Investment Landscape Analysis60%

see_also📖ER Stress & UPR Therapeutics Investment Landscape60%

see_also📖GLP-1 Receptor Agonist Therapeutics Investment Landscape60%

see_also📖Heat Shock Protein (HSP) Therapeutics for Neurodegeneration60%

see_also📖Lysosomal Dysfunction Therapeutics Investment Landscape60%

see_also📖Microbiome-Based Therapeutics for Neurodegeneration: Investm60%

see_also📖Mitochondrial Therapeutics Investment Landscape60%

see_also📖Peptide Therapeutics for Neurodegeneration — Investment Land60%

see_also📖Protein Aggregation Inhibitors for Neurodegeneration — Inves60%

see_also📖RNA Therapeutics: Investment Landscape Analysis60%

see_also📖Senolytic Therapeutics: Investment Landscape Analysis60%

see_also📖Anti-Amyloid Therapeutics: Successes, Failures, and Lessons 60%

see_also📖Biomarkers of Alzheimer Disease60%

see_also📖Biomarkers in Neurodegeneration60%

see_also📖Biomarkers for Parkinson's Disease60%

see_also📖Denali Therapeutics60%

see_also📖Digital Therapeutics for Neurodegenerative Diseases60%

see_also📖RNA Editing Therapeutics60%

see_also📖therapeutics60%

see_also📖Anti-Amyloid Therapeutics60%

see_also📖Anti-Tau Therapeutics60%

see_also📖Cyclophosphamide60%

see_also📖Exosome-Based Therapeutics for Neurodegenerative Diseases60%

see_also📖Mitochondrial Therapeutics60%

see_also📖Neurotrophic Factor Therapies for Neurodegenerative Diseases60%

see_also📖TGF-beta Signaling Therapies for Neurodegeneration60%

see_also📖UBE3A60%

see_also📖CREB3 Gene60%

see_also📖PINK1 — PTEN Induced Kinase 1 (PARK6)60%

see_also📖slc1a3 Gene60%

see_also📖TNFRSF1B Gene60%

see_also📖UBE3A Gene60%

see_also📖NRF2 Activator Therapy60%

see_also📖MAOA Gene60%

see_also📖NDUFV1 Gene60%

see_also📖PLEC Gene60%

mentions🔬What are the mechanisms underlying 4r-tau strain-specific sp50%

mentions🔬What are the mechanisms underlying astrocyte reactivity subt50%

mentions🔬What are the mechanisms underlying microglia-astrocyte cross50%

mentions🔬What are the mechanisms underlying neuroinflammation resolut50%

mentions🔬What are the mechanisms underlying mitochondrial transfer be50%

mentions🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc50%

mentions🔬Senescent cell clearance as neurodegeneration therapy50%

mentions🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas50%

mentions🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer50%

mentions🧪APOE4 Allosteric Rescue via Small Molecule Chaperones50%

mentions🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction50%

mentions🧪Targeted APOE4-to-APOE3 Base Editing Therapy50%

mentions🧪Competitive APOE4 Domain Stabilization Peptides50%

mentions🧪Glymphatic System-Enhanced Antibody Clearance Reversal50%

mentions🧪SASP-Driven Aquaporin-4 Dysregulation50%

mentions🧪Palmitoylation-Targeted BACE1 Trafficking Disruptors50%

mentions🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna50%

mentions🧪Complement C1q Mimetic Decoy Therapy50%

mentions🧪Circadian Clock-Autophagy Synchronization50%

mentions🧪Optogenetic Microglial Deactivation via Engineered Inhibitor50%

mentions🧪Fractalkine Axis Amplification via CX3CR1 Positive Allosteri50%

mentions🧪FOXO3-Longevity Pathway Epigenetic Reprogramming50%

mentions🧪Astroglial Gap Junction Coordination via Connexin-43 Phospho50%

mentions🧪LRP1-Dependent Tau Uptake Disruption50%

mentions🧪SASP-Mediated Cholinergic Synapse Disruption50%

mentions🧪Pericyte Contractility Reset via Selective PDGFR-β Agonism50%

mentions🧪Perforant Path Presynaptic Terminal Protection Strategy50%

mentions🧪Prefrontal sensory gating circuit restoration via PV interne50%

mentions🧪Nutrient-Sensing Epigenetic Circuit Reactivation50%

mentions🧪Mitochondrial-Nuclear Epigenetic Cross-Talk Restoration50%

mentions🧪Synaptic Vesicle Tau Capture Inhibition50%

mentions🧪Temporal TET2-Mediated Hydroxymethylation Cycling50%

mentions🧪TET2-Mediated Demethylation Rejuvenation Therapy50%

mentions🧪TREM2 Conformational Stabilizers for Synaptic Discrimination50%

mentions🧪TREM2-mediated microglial tau clearance enhancement50%

related🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas50%

related🔬What are the mechanisms underlying 4r-tau strain-specific sp50%

related🔬What are the mechanisms underlying astrocyte reactivity subt50%

related🔬What are the mechanisms underlying microglia-astrocyte cross50%

related🔬What are the mechanisms underlying neuroinflammation resolut50%

related🔬What are the mechanisms underlying mitochondrial transfer be50%

related🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc50%

related🔬Senescent cell clearance as neurodegeneration therapy50%

related🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas50%

related🔬What are the mechanisms underlying blood-brain barrier trans50%

related🔬What are the mechanisms underlying synaptic pruning by micro50%

related🔬Analyze circuit-level changes in neurodegeneration using All50%

related🧪Temporal Decoupling via Circadian Clock Reset40%

related🧪Netrin-1 Gradient Restoration40%

related🧪Purinergic Signaling Polarization Control40%

related🧪Mitochondrial SPM Synthesis Platform Engineering40%

related🧪CX43 hemichannel engineering enables size-selective mitochon40%

related🧪RAB27A-dependent extracellular vesicle engineering for mitoc40%

related🧪Designer TRAK1-KIF5 fusion proteins accelerate therapeutic m40%

related🧪Metabolic Circuit Breaker via Lipid Droplet Modulation40%

related🧪Senescent Microglia Resolution via Maresins-Senolytics Combi40%

related🧪AMPK hypersensitivity in astrocytes creates enhanced mitocho40%

related🧪Microglial Efferocytosis Enhancement via GPR32 Superagonists40%

related🧪Biorhythmic Interference via Controlled Sleep Oscillations40%

related🧪Quantum Coherence Disruption in Cellular Communication40%

related🧪Circadian Rhythm Entrainment of Reactive Astrocytes40%

related🧪Complement C1q Subtype Switching40%

related🧪Microglial Purinergic Reprogramming40%

related🧪Sphingolipid Metabolism Reprogramming40%

related🧪GAP43-mediated tunneling nanotube stabilization enhances neu40%

related🧪Extracellular Matrix Stiffness Modulation40%

related🧪Lipid Droplet Dynamics as Phenotype Switches40%

related🧪Circadian-Gated Maresin Biosynthesis Amplification40%

related🧪Blood-Brain Barrier SPM Shuttle System40%

related🧪Mitochondrial Transfer Pathway Enhancement40%

related🧪TFAM overexpression creates mitochondrial donor-recipient gr40%

related🧪Metabolic Switch Targeting for A1→A2 Repolarization40%

related🧪Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th40%

related🧪Glial Glycocalyx Remodeling Therapy40%

related🧪Aquaporin-4 Polarization Rescue40%

related🧪Epigenetic Memory Erasure via TET2 Activation40%

related🧪Mechanosensitive Ion Channel Reprogramming40%

related🧪Synthetic Biology Rewiring via Orthogonal Receptors40%

related🧪Ephrin-B2/EphB4 Axis Manipulation40%

related🧪Phase-Separated Organelle Targeting40%

related🧪Oligodendrocyte Protectin D1 Mimetic for Myelin Resolution40%

related🧪Near-infrared light therapy stimulates COX4-dependent mitoch40%

related🧪Cell-Type Specific TREM2 Upregulation in DAM Microglia40%

related🧪Complement C1QA Spatial Gradient in Cortical Layers40%

related🧪Excitatory Neuron Vulnerability via SLC17A7 Downregulation40%

related🧪APOE Isoform Expression Across Glial Subtypes40%

related🧪ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro40%

related🧪Astrocyte MCT1/MCT4 Ratio Disruption with Metabolic Uncoupli40%

related🧪SIRT3-Mediated Mitochondrial Deacetylation Failure with PINK40%

related🧪SASP-Mediated Cholinergic Synapse Disruption40%

related🔬What are the mechanisms underlying neuroinflammation resolut40%

related🔬SPMs (resolvins, protectins, maresins) from omega-3s may pro40%

related🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc40%

related🔬What are the mechanisms underlying mitochondrial transfer be40%

related🔬Mitochondrial transfer between astrocytes and neurons40%

related🔬PSP and CBD both involve 4R-tau but produce distinct neuropa40%

related🔬Senescent cell clearance as neurodegeneration therapy40%

related🔬What are the mechanisms underlying microglia-astrocyte cross40%

related🔬Microglia activate astrocytes via IL-1alpha/TNF/C1q, and rea40%

related🔬What are the mechanisms underlying astrocyte reactivity subt40%

related🔬Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) ph40%

related🔬What are the mechanisms underlying 4r-tau strain-specific sp24%